CAS: 331770-21-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide REF: IN-DA01EPC8CAS: 331770-21-9 | 97% | A consultar | Lun 21 Abr 25 |
 | Aurora kinase inhibitor-2 REF: 54-BUP08242CAS: 331770-21-9 | 99.15% | 570,00 €~1.519,00 € | Mar 22 Abr 25 |
 | Aurora kinase inhibitor-2 REF: TM-T9040CAS: 331770-21-9 | 98.66% | 66,00 €~1.121,00 € | Lun 28 Abr 25 |
![N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide](https://static.cymitquimica.com/products/IN/thumb/DA01EPC8.jpg)
N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide
CAS:331770-21-9
Fórmula:
C23H20N4O3
Pureza:
97%
Forma y color:
Solid
Peso molecular:
400.4299
Ref: IN-DA01EPC8
| 5mg | 185,00 € | ||
| 10mg | 225,00 € | ||
| 25mg | 597,00 € | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 21 de Abril de 2025
Ref: 54-BUP08242
| 25mg | 570,00 € | ||
| 50mg | 825,00 € | ||
| 100mg | 1.222,00 € | ||
| 200mg | 1.519,00 € |
Entrega estimada en Estados Unidos, el Martes 22 de Abril de 2025
Aurora kinase inhibitor-2
CAS:331770-21-9
Aurora kinase inhibitor-2 (IUN-70219) is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A …
Fórmula:
C23H20N4O3
Pureza:
98.66%
Forma y color:
Solid
Peso molecular:
400.43
Ref: TM-T9040
| 1mg | 66,00 € | ||
| 5mg | 145,00 € | ||
| 10mg | 212,00 € | ||
| 25mg | 380,00 € | ||
| 50mg | 562,00 € | ||
| 100mg | 832,00 € | ||
| 200mg | 1.121,00 € | ||
| 1mL*10mM (DMSO) | 167,00 € |
Entrega estimada en Estados Unidos, el Lunes 28 de Abril de 2025
